Charles Schwab’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.55M Sell
1,992,451
-24,230
-1% -$135K ﹤0.01% 2181
2025
Q4
$18.1M Sell
2,016,681
-38,814
-2% -$240K ﹤0.01% 1813
2025
Q3
$7.61M Sell
2,055,495
-75,404
-4% -$205K ﹤0.01% 2238
2025
Q2
$4.16M Buy
2,130,899
+226,758
+12% +$472K ﹤0.01% 2408
2025
Q1
$3.35M Sell
1,904,141
-41,842
-2% -$95.2K ﹤0.01% 2438
2024
Q4
$5.18M Buy
1,945,983
+551,968
+40% +$1.42M ﹤0.01% 2323
2024
Q3
$3.19M Buy
1,394,015
+60,590
+5% +$185K ﹤0.01% 2569
2024
Q2
$3.89M Buy
1,333,425
+185,398
+16% +$566K ﹤0.01% 2455
2024
Q1
$4.18M Buy
1,148,027
+21,364
+2% +$41K ﹤0.01% 2345
2023
Q4
$1.7M Buy
1,126,663
+84,510
+8% +$109K ﹤0.01% 2666
2023
Q3
$1.4M Buy
1,042,153
+2,363
+0.2% +$3.93K ﹤0.01% 2694
2023
Q2
$1.87M Buy
1,039,790
+85,989
+9% +$146K ﹤0.01% 2569
2023
Q1
$1.58M Buy
953,801
+65,675
+7% +$133K ﹤0.01% 2585
2022
Q4
$1.71M Sell
888,126
-74,617
-8% -$151K ﹤0.01% 2618
2022
Q3
$2.16M Buy
962,743
+138,558
+17% +$396K ﹤0.01% 2564
2022
Q2
$2.67M Sell
824,185
-116,852
-12% -$510K ﹤0.01% 2470
2022
Q1
$4.95M Buy
941,037
+33,364
+4% +$187K ﹤0.01% 2282
2021
Q4
$7.72M Buy
907,673
+212,255
+31% +$1.95M ﹤0.01% 2136
2021
Q3
$6.91M Buy
695,418
+317,882
+84% +$2.88M ﹤0.01% 2221
2021
Q2
$3.52M Buy
377,536
+82,092
+28% +$936K ﹤0.01% 2522
2021
Q1
$3.09M Buy
+295,444
New +$3.3M ﹤0.01% 2529

Other funds holding NUVB